OneDigital Investment Advisors LLC purchased a new stake in shares of Molina Healthcare, Inc (NYSE:MOH – Free Report) during the 1st quarter, according to the company in its most recent filing with the SEC. The fund purchased 820 shares of the company’s stock, valued at approximately $270,000.
Other large investors have also added to or reduced their stakes in the company. Amalgamated Bank raised its holdings in shares of Molina Healthcare by 0.3% during the first quarter. Amalgamated Bank now owns 11,580 shares of the company’s stock valued at $3,814,000 after acquiring an additional 33 shares during the last quarter. Deseret Mutual Benefit Administrators raised its holdings in shares of Molina Healthcare by 60.7% during the first quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company’s stock valued at $30,000 after acquiring an additional 34 shares during the last quarter. JLB & Associates Inc. raised its holdings in shares of Molina Healthcare by 0.3% during the first quarter. JLB & Associates Inc. now owns 10,626 shares of the company’s stock valued at $3,500,000 after acquiring an additional 36 shares during the last quarter. Angeles Investment Advisors LLC raised its holdings in shares of Molina Healthcare by 5.4% during the fourth quarter. Angeles Investment Advisors LLC now owns 838 shares of the company’s stock valued at $244,000 after acquiring an additional 43 shares during the last quarter. Finally, Coldstream Capital Management Inc. raised its holdings in shares of Molina Healthcare by 2.1% during the fourth quarter. Coldstream Capital Management Inc. now owns 2,346 shares of the company’s stock valued at $683,000 after acquiring an additional 48 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company’s stock.
Insiders Place Their Bets
In other Molina Healthcare news, Director Richard M. Schapiro sold 669 shares of Molina Healthcare stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total value of $214,414.50. Following the completion of the sale, the director owned 11,244 shares in the company, valued at $3,603,702. The trade was a 5.62% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the business’s stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the completion of the transaction, the chief executive officer owned 257,715 shares of the company’s stock, valued at $82,484,262.90. The trade was a 25.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.10% of the company’s stock.
Molina Healthcare Price Performance
Molina Healthcare (NYSE:MOH – Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.96 by $0.12. Molina Healthcare had a return on equity of 28.38% and a net margin of 2.81%. The company had revenue of $11.15 billion for the quarter, compared to analysts’ expectations of $10.86 billion. During the same quarter in the prior year, the company earned $5.73 earnings per share. The firm’s revenue was up 12.2% on a year-over-year basis. Equities research analysts anticipate that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on the company. Baird R W lowered Molina Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 15th. Guggenheim assumed coverage on Molina Healthcare in a research report on Wednesday, April 9th. They issued a “neutral” rating for the company. Wall Street Zen lowered Molina Healthcare from a “buy” rating to a “hold” rating in a research report on Sunday, June 29th. Truist Financial increased their price objective on Molina Healthcare from $340.00 to $400.00 and gave the stock a “buy” rating in a research report on Friday, April 11th. Finally, Morgan Stanley lowered Molina Healthcare from an “overweight” rating to an “equal weight” rating and lowered their price objective for the stock from $364.00 to $266.00 in a research report on Thursday. Eleven investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $352.21.
View Our Latest Research Report on Molina Healthcare
Molina Healthcare Profile
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Read More
- Five stocks we like better than Molina Healthcare
- 3 Small Caps With Big Return Potential
- Power Solutions International Poised for 75% Upside
- ESG Stocks, What Investors Should Know
- Why Wall Street Is Betting on These 3 Comeback Stocks
- What Does Downgrade Mean in Investing?
- Smart Investors Are Watching These 3 Undervalued Stocks
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.